Related by context. Frequent words. (Click for all words.) 63 tamoxifen therapy 54 mg kg dose 53 warfarin therapy 52 neoadjuvant chemotherapy 52 sustained virologic response 52 coronary revascularization 52 abiraterone acetate 52 virologic response 52 adjuvant chemotherapy 52 elagolix 52 antidepressant therapy 52 adjuvant therapy 52 cytogenetic response 52 vertebral fracture 52 dose cohorts 51 virologic failure 51 mcg dose 51 tesmilifene 50 IMC A# 50 HER2 positive metastatic breast 50 premenopausal 50 neoadjuvant 50 nab paclitaxel 49 GVAX 49 Allovectin 7 R 49 chemoradiation 49 chemoradiotherapy 49 Phase 2b study 49 Phase 2a trial 49 Amrubicin 49 placebo controlled clinical 49 resale restriction 49 XELOX 49 Phase Ia 48 confirmatory Phase 3 48 Asentar 48 Phase IIa clinical trials 48 PROMACTA 48 mg BID 48 decitabine 48 phase IIa 48 placebo controlled trials 48 adalimumab 48 Median survival 48 exemestane 48 placebo controlled studies 48 HbA1c levels 48 dose escalation 47 T2DM 47 Stedivaze 47 liver metastases 47 blinded placebo controlled 47 multiple ascending dose 47 Secondary endpoints 47 glufosfamide 47 HCV infected 47 dose regimens 47 axitinib 47 placebo controlled randomized 47 Phase 1b trial 47 Phase 2b trial 46 events SAEs 46 Phase 1a 46 median PFS 46 confirmatory Phase III 46 double blinded placebo 46 HGS ETR1 46 nortriptyline 46 aclidinium 46 Azedra 46 Phase 1b clinical 46 secondary efficacy endpoints 46 phase 2a 46 statin therapy 46 Zerenex 45 hemoglobin concentration 45 QTc 45 postmenopausal women 45 Phase IIa trial 45 romidepsin 45 aflibercept 45 darapladib 45 registrational 45 ponatinib 45 neoadjuvant therapy 45 Northera 45 distant metastases 45 BLA submission 45 tumor shrinkage 45 TELCYTA 45 mg dose 45 free survival PFS 45 LVEF 45 phase IIb 45 prospective observational 45 randomisation 44 events AEs 44 evaluable 44 cardiac dysfunction 44 RECIST criteria 44 Secondary endpoints include